Income investors holding iShares MSCI Europe Financials ETF (NASDAQ:EUFN) are sitting on a fund that has done two things at once: handed them a roughly 3.5% yield and delivered a 28% one-year return. The question every EUFN holder should be asking is whether the income side of that equation is built on durable bank and ... Why EUFN’s Juicy Payouts Could Vanish Overnight Without U.S. Bank ETF Safeg...
Income investors holding iShares MSCI Europe Financials ETF (NASDAQ:EUFN) are sitting on a fund that has done two things at once: handed them a roughly 3.5% yield and delivered a 28% one-year return. The question every EUFN holder should be asking is whether the income side of that equation is built on durable bank and ... Why EUFN’s Juicy Payouts Could Vanish Overnight Without U.S. Bank ETF Safeguards
Bet_Noire/iStock via Getty Images I started coverage of Whirlpool ( WHR ) back in 2024 with an initial neutral rating , I turned more bullish in 2024, primarily based on the firm's attractive dividend payments, and attractive valuation metrics at that time. Earlier this year, I once again became more cautious and downgraded WHR from buy to hold. The main reasons for my downgrade were the weak hous...
Bet_Noire/iStock via Getty Images I started coverage of Whirlpool ( WHR ) back in 2024 with an initial neutral rating , I turned more bullish in 2024, primarily based on the firm's attractive dividend payments, and attractive valuation metrics at that time. Earlier this year, I once again became more cautious and downgraded WHR from buy to hold. The main reasons for my downgrade were the weak housing market, poor consumer sentiment and elevated energy prices - but I still found the firm attractive based on its dividends. This is no longer the case, however, as the firm suspended its dividend payments, due to the extreme margin compression, and shifted their focus on reducing debt. Without the dividend, I no longer think it is worth holding the stock to wait for a turnaround to materialize. Results Let us start our discussion by looking at the most recent quarterly results and highlighting the key drivers why WHR is struggling so much right now. First, the net sales declined by as much as 9.6%, which was driven by a 6.1% organic decline due to poor demand. Q1 results (Whirlpool) The declining sales is not the only issue though. In the firm's largest segment MDA NAR, not only sales fell, but the margin also contracted very dramatically. And by very dramatic I mean roughly 95% YoY. MDA NAR (Whirlpool) Furthermore, the firm also expects the headwinds to keep negatively impacting the results in full year 2026. As a result, their guidance hit a much more pessimistic tone than before, expecting sales and EBIT to be both declining. Segment guidance (Whirlpool) Overall, they hit a very negative tone, when talking about the results, comparing the current collapse in demand and margins to previous crisis environments, like 2001, 2007-2009 and 2020. Industry decline (Whirlpool) In my view, based on these fundamentals, it is no longer worth owning WHR. When looking at consumer confidence, a key leading economic indicator, I also cannot get too optimistic about a quick turnaround...
Welcome to our guide to the commodities driving the global economy. Today, reporter Alex Longley looks at the factors helping to shield the oil market from the effects of the Iran war and the risks ahead. Ever since the war in Iran began, the oil market has been pulling every lever it can to make sure the world has enough supply. In the past few weeks, two measures in particular have come to the f...
Welcome to our guide to the commodities driving the global economy. Today, reporter Alex Longley looks at the factors helping to shield the oil market from the effects of the Iran war and the risks ahead. Ever since the war in Iran began, the oil market has been pulling every lever it can to make sure the world has enough supply. In the past few weeks, two measures in particular have come to the fore. Traders are now questioning how much longer they can be sustained. The first has been an unprecedented surge in US exports. Toward the end of last month, the country was exporting more than 14 million barrels of crude and refined products a day, an all-time high. The increase has been propelled in part by efforts to tap emergency stockpiles , with the latest weekly drawdown totaling a record 1.22 million barrels a day. Those releases have more room to run. But they can’t continue indefinitely, and pressure on inventories is likely to intensify as the summer driving season approaches. The other key factor keeping a lid on prices has been less obvious, but arguably more impactful — a sudden collapse in Chinese crude purchases. Some of the nation’s large oil companies have been reselling cargoes from West Africa in recent weeks. The move came shortly after state refiners were given permission to draw from commercial storage, helping to ease supply pressures. Crude futures are up almost 50% since the start of the war, with the effective closure of the crucial Strait of Hormuz keeping vast quantities locked up in the Persian Gulf. But prices haven’t breached levels seen in 2022, when Russia’s full-scale invasion of Ukraine drove benchmark Brent toward $130 a barrel. The boss of trading house Mercuria Energy Group Ltd. said late last month that Chinese selling had “taken out a lot of demand from various countries,” but that the move could only continue for another three weeks or so. Morgan Stanley also said that China’s slowing imports — and America’s robust exports — can’t ...
Over the last 7 days, the United States market has risen 2.6% and is up 26% over the last 12 months, with earnings forecasted to grow by 17% annually. In this favorable environment, growth companies with strong insider ownership can be particularly appealing as they often align management's interests with those of shareholders, potentially driving long-term value creation.
Over the last 7 days, the United States market has risen 2.6% and is up 26% over the last 12 months, with earnings forecasted to grow by 17% annually. In this favorable environment, growth companies with strong insider ownership can be particularly appealing as they often align management's interests with those of shareholders, potentially driving long-term value creation.
adventtr Quantum Computing ( QUBT ) was in focus on Tuesday as the quantum computing company said its first-quarter revenue surged nearly 9,000%. As such, Wedbush Securities believes the firm has become “bigger [and] better” due to acquisitions, and its story is still in the “early days.” Shares jumped nearly 25% in premarket trading, while other quantum stocks, such as Rigetti Computing ( RGTI ),...
adventtr Quantum Computing ( QUBT ) was in focus on Tuesday as the quantum computing company said its first-quarter revenue surged nearly 9,000%. As such, Wedbush Securities believes the firm has become “bigger [and] better” due to acquisitions, and its story is still in the “early days.” Shares jumped nearly 25% in premarket trading, while other quantum stocks, such as Rigetti Computing ( RGTI ), IonQ ( IONQ ), and D-Wave Quantum ( QBTS ) also rose. Rigetti also reported first-quarter results. “We continue to expect the recently completed acquisition of LSI to contribute between $20M to $25M in revenue in 2026, with LSI expected to bolster QUBT's semiconductor capabilities that will expand the company's addressable market and strengthen its ability to deliver integrated photonic solutions at scale,” Wedbush analyst Antoine Legault wrote in a note to clients. “Net, while we are encouraged by the company's 1Q26 results and forward commentary, we maintain our NEUTRAL rating and $12 PT on QUBT and continue to view the company as a 'show me' story given it remains at an earlier stage of development than its public peers with a considerably lower quantum hardware revenue base.” Hoboken, N.J.-based Quantum Computing said first-quarter revenue was $3.69M, which was above the $3.28M estimate. Revenue was aided by the acquisitions of Luminar Semiconductors in February 2026 and NuCrypt in March 2026. The company ended the quarter with $1.4B in cash and equivalents and a $16M contract backlog. More on Quantum Computing Quantum Computing Inc. (QUBT) Q1 2026 Earnings Call Transcript D-Wave Quantum Vs. Quantum Computing: Early Revenue Premium Masks Long-Term Parity Quantum Computing: Rating Upgrade After Q4 Inflection Quarter Biggest stock movers Tuesday: PLUG, HIMS, and more Quantum Computing outlines Fab 2 planning as Q1 revenue reaches $3.7M following Luminar and NuCrypt acquisitions
Keir Starmer was facing growing pressure to step down as Britain’s prime minister after dozens of members of Parliament, including Cabinet allies, joined the calls for him to set out a timetable for his departure. The pound extended losses and Gilts came under further pressure, with the yield on 10-year notes jumping beyond 5.10%. The yield on 30-year debt hit its highest level since 1998. The Ope...
Keir Starmer was facing growing pressure to step down as Britain’s prime minister after dozens of members of Parliament, including Cabinet allies, joined the calls for him to set out a timetable for his departure. The pound extended losses and Gilts came under further pressure, with the yield on 10-year notes jumping beyond 5.10%. The yield on 30-year debt hit its highest level since 1998. The Opening Trade has everything you need to know as markets open across Europe. With analysis you won't find anywhere else, we break down the biggest stories of the day and speak to top guests who have skin in the game. Hosted by Anna Edwards, Guy Johnson and Tom Mackenzie. (Source: Bloomberg)
A Spanish passenger evacuated from the cruise ship at the centre of a hantavirus outbreak has tested positive for the virus, Spain’s health ministry announced on Tuesday as the World Health Organization said it has now confirmed 11 cases, including three people from the cruise who died. The passenger with the new confirmed case of hantavirus was in quarantine in a military hospital in Madrid, wher...
A Spanish passenger evacuated from the cruise ship at the centre of a hantavirus outbreak has tested positive for the virus, Spain’s health ministry announced on Tuesday as the World Health Organization said it has now confirmed 11 cases, including three people from the cruise who died. The passenger with the new confirmed case of hantavirus was in quarantine in a military hospital in Madrid, where 13 other Spanish nationals evacuated on Sunday – who all tested negative for the virus – also are...
Lorado/E+ via Getty Images Co-authored with Beyond Saving The market indices are trading near all-time highs and are trading near all-time high valuations. Yardeni This is simply a fact. People can argue over whether there is something unique about the mega-caps driving the S&P 500 higher or whether something has changed that makes a 21x price/earnings an attractive valuation, but you can't argue ...
Lorado/E+ via Getty Images Co-authored with Beyond Saving The market indices are trading near all-time highs and are trading near all-time high valuations. Yardeni This is simply a fact. People can argue over whether there is something unique about the mega-caps driving the S&P 500 higher or whether something has changed that makes a 21x price/earnings an attractive valuation, but you can't argue that historically, the average of 21x P/E is much higher than usual. I tend to be a believer in history rhyming, and we can see on this chart what happened in the past when the P/E ratio for the S&P 500 was this high. Of course, that doesn't mean everything in the market is expensive. The red line above is the median P/E ratio, the point where 50% of companies fall below, and 50% of companies are above. Currently, that line is 18.5x price/earnings. In the stock market, I'm a bargain shopper at heart. I'm never paying +20x P/E for anything. My goal is to buy investments that are trading at a low valuation and collect dividends. If the valuation gets high, I'll sell and find something else that is inexpensive. Today, we're going to take a look at two companies that are trading at low valuations. These companies had some issues over the past five years that have left them cast aside by a market willing to pay a premium for the next shiny thing. Both companies are trading at bargain valuations that we expect will rise in the near to mid-future. Let's dive in! Pick #1: EPR – Yield 6.4% In our last article on EPR Properties ( EPR ) before earnings, we predicted : "We are confident that EPR has other irons in the fire and will be increasing its acquisition guidance, which will also lead to an increase in FFOAA (FFO As Adjusted) guidance for 2026. EPR is trading at only 10x FFOAA based on prior guidance. An increase in guidance and an increased expected growth rate should drive the price higher and inspire the market to trade EPR at a higher multiple." Sure enough, they increased g...
MicroStockHub/iStock via Getty Images Arvinas ( ARVN ) announced on Tuesday that the company and its partner, Pfizer ( PFE ), reached an agreement with Rigel Pharmaceuticals ( RIGL ) to sell global licensing rights to their jointly developed breast cancer therapy, Veppanu (vepdegestrant), to Rigel ( RIGL ). The protein degrader therapy was approved by the FDA earlier this month for a subset of adu...
MicroStockHub/iStock via Getty Images Arvinas ( ARVN ) announced on Tuesday that the company and its partner, Pfizer ( PFE ), reached an agreement with Rigel Pharmaceuticals ( RIGL ) to sell global licensing rights to their jointly developed breast cancer therapy, Veppanu (vepdegestrant), to Rigel ( RIGL ). The protein degrader therapy was approved by the FDA earlier this month for a subset of adults with breast cancer. Under the collaboration, Rigel ( RIGL ) will take responsibility for the launch and commercialization of Veppanu in the U.S. by giving $70M upfront to Arvinas ( ARVN ) and Pfizer ( PFE ). The duo will also receive $15M in additional payments, subject to the completion of certain development and manufacturing activities, as well as up to $320M in milestone payments and tiered royalties on net sales in the mid-teens to mid-20s. The companies will equally share the payments. As part of the deal, Rigel ( RIGL ) will also receive global rights to Veppanu, including rights to sublicense the drug in overseas territories to future partners. In exchange, Arvinas ( ARVN ) and Pfizer ( PFE ) will be eligible for a percentage of sublicensing revenue earned outside the U.S. The partnership further specifies that the duo will receive up to a $40M contribution from Rigel ( RIGL ) to continue their ongoing R&D activities related to vepdegestrant . The collaboration was announced in conjunction with Arvinas’ ( ARVN ) Q1 2026 results on Tuesday. More on Pfizer, Rigel Pharmaceuticals, etc. Rigel Pharmaceuticals, Inc. (RIGL) Q1 2026 Earnings Call Transcript Rigel Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation Pfizer Inc. (PFE) Q1 2026 Earnings Call Transcript FDA asks for feedback on repurposing drugs for new indications Arvinas Q1 2026 Earnings Preview
AndreyPopov/iStock via Getty Images Introduction In my last article on PayPal Holdings, Inc. ( PYPL ), I highlighted interest by a super investor with a Buffett-like mindset. Since then, PYPL has been my worst performer, trailing the S&P 500 by almost 50%. PYPL Performance since Previous Article (Seeking Alpha) A lot has changed besides the price movement, especially with former CEO Alex Chriss be...
AndreyPopov/iStock via Getty Images Introduction In my last article on PayPal Holdings, Inc. ( PYPL ), I highlighted interest by a super investor with a Buffett-like mindset. Since then, PYPL has been my worst performer, trailing the S&P 500 by almost 50%. PYPL Performance since Previous Article (Seeking Alpha) A lot has changed besides the price movement, especially with former CEO Alex Chriss being replaced by the former HP Inc. ( HPQ ) CEO, Enrique Lores. While the market did not like this decision, I think it's actually a wonderful hire since PYPL will now transition to a similar playbook to HPQ , which I have written about here. Slow growth, cheap valuations, accretive buybacks, and operational efficiency will be the name of the game moving forward. Because of this, I still am bullish on this ticker even with the recent performance. Essentially, PYPL may not need a return to hypergrowth to generate strong shareholder returns. The story here is much simpler in my opinion. The stock looks cheap, management is focused on reducing operating expenses, and the company continues aggressively repurchasing shares using billions in annual free cash flow. The market currently appears focused on slowing growth, margin pressure, and increasing competition from companies like Apple Pay, Stripe, Shopify, and Block. As a result, PayPal's valuation has compressed significantly over the past several years. However, the business itself still generates enormous amounts of cash flow and remains highly profitable. In my view, investors may be underestimating how powerful continued cost reductions and share repurchases can become when executed at depressed valuation levels. Management now appears focused on the right priorities. During the recent earnings call, CEO Enrique Lores discussed simplifying the organization, improving efficiency, using AI to reduce costs, and streamlining operations. Management expects these initiatives to generate at least $1.5 billion in gross run-rate sa...
Prelude Therapeutics press release ( PRLD ): Q1 GAAP EPS of -$0.13 beats by $0.12 . Revenue of $4.58M. More on Prelude Therapeutics Prelude Therapeutics prices $90M equity offering Seeking Alpha’s Quant Rating on Prelude Therapeutics Historical earnings data for Prelude Therapeutics Financial information for Prelude Therapeutics
Prelude Therapeutics press release ( PRLD ): Q1 GAAP EPS of -$0.13 beats by $0.12 . Revenue of $4.58M. More on Prelude Therapeutics Prelude Therapeutics prices $90M equity offering Seeking Alpha’s Quant Rating on Prelude Therapeutics Historical earnings data for Prelude Therapeutics Financial information for Prelude Therapeutics
At Holdings Channel, we have reviewed the latest batch of the 60 most recent 13F filings for the 03/31/2026 reporting period, and noticed that Uber Technologies Inc (Symbol: UBER) was held by 24 of these funds. When hedge fund managers appear to be thinking alike, we find it is
At Holdings Channel, we have reviewed the latest batch of the 60 most recent 13F filings for the 03/31/2026 reporting period, and noticed that Uber Technologies Inc (Symbol: UBER) was held by 24 of these funds. When hedge fund managers appear to be thinking alike, we find it is